Bausch & Lomb Corp balance sheet
At the end of fiscal 2025, Bausch & Lomb Corp had total assets of $14.02bn, total liabilities of $7.50bn and shareholders' equity of $6.45bn. It held $383m in cash against $5.11bn of debt: net debt of $4.72bn.
Balance sheet
| Fiscal year | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 0.2 | 0.2 | 0.4 | 0.3 | 0.3 | 0.4 | 0.5 |
| Receivables | — | 0.7 | 0.7 | 0.8 | 1.0 | 1.2 | 1.1 |
| Inventory | — | 0.6 | 0.6 | 1.0 | 1.0 | 1.0 | 1.0 |
| Total current assets | — | 1.6 | 2.1 | 2.7 | 2.8 | 3.0 | 3.1 |
| Goodwill | 4.7 | 4.6 | 4.5 | 4.6 | 4.5 | 4.8 | 4.7 |
| Total assets | — | 10.8 | 11.1 | 13.4 | 13.5 | 14.0 | 14.0 |
| Accounts payable | — | 0.2 | 0.4 | 0.5 | 0.4 | 0.4 | 0.4 |
| Total current liabilities | — | 1.1 | 1.3 | 1.6 | 1.7 | 1.9 | 2.0 |
| Short-term debt | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term debt | — | 0.0 | 2.4 | 4.5 | 4.7 | 5.0 | 5.0 |
| Total debt | 0.0 | 0.0 | 2.5 | 4.6 | 4.8 | 5.1 | 5.1 |
| Total liabilities | — | 1.4 | 4.0 | 6.5 | 6.9 | 7.5 | 7.4 |
| Shareholders' equity | 10.0 | 9.3 | 7.0 | 6.9 | 6.5 | 6.4 | 6.4 |
| Net debt (negative = net cash) | −0.2 | −0.2 | 2.1 | 4.3 | 4.5 | 4.7 | 4.6 |
| Shares outstanding | — | 350m | 350m | 351m | 352m | 354m | 357m |
| Quarter | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 | 2026 Q3Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| Receivables | 1.0 | 1.0 | 1.1 | 1.1 | 1.2 | 1.1 | 1.2 | 1.1 |
| Inventory | 1.0 | 1.0 | 1.1 | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 |
| Total current assets | 2.8 | 2.7 | 2.8 | 2.9 | 3.0 | 2.8 | 2.9 | 3.1 |
| Goodwill | 4.5 | 4.6 | 4.7 | 4.7 | 4.8 | 4.7 | 4.7 | 4.7 |
| Total assets | 13.5 | 13.4 | 13.8 | 13.8 | 14.0 | 13.8 | 13.9 | 14.0 |
| Accounts payable | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 |
| Total current liabilities | 1.7 | 1.7 | 1.8 | 1.9 | 1.9 | 1.8 | 1.9 | 2.0 |
| Short-term debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term debt | 4.7 | 4.8 | 4.9 | 4.9 | 5.0 | 5.0 | 5.0 | 5.0 |
| Total debt | 4.8 | 4.8 | 5.0 | 5.0 | 5.0 | 5.0 | 5.1 | 5.0 |
| Total liabilities | 6.9 | 7.0 | 7.3 | 7.3 | 7.5 | 7.3 | 7.4 | 7.4 |
| Shareholders' equity | 6.5 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 |
| Shares outstanding | 352m | 353m | 354m | 354m | 354m | 356m | 357m | 357m |
Compare with peers
- ResMed| balance sheet
- Dexcom balance sheet
- Steris balance sheet
- Idexx Laboratories balance sheet
- Edwards Lifesciences balance sheet
Head to head: BLCO vs RMDBLCO vs DXCMBLCO vs STEBLCO vs IDXX
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies